Company
Every investor coverage indicates participated in a round Healius Pathology raised.
Companies Healius Pathology acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Healius Pathology. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Analysis of rising shareholder activism: Lendlease's chairman departs under Tanarra pressure, activists push Karoon over dividends, Tanarra surfaces on Bapcor's register, and L1 Capital runs an activist fund.
Federal grants roundup: 21 Cooperative Research Centres Projects awards worth $51 million in Round 15, with EQ Plastics, Optiscan Imaging and NEXSEN BioTech each receiving $3 million for product development.
Also RenewEconomy
Weekly roundup reporting Australian raises including Zero Co, MOBI and CipherStash, Cashrewards' takeover agreement, Shebah's collapse, WeWork's NYSE listing, crypto regulation recommendations and SiteMinder board appointments.
Also Australian FinTech·Cut Through Venture·Startup Daily·SmartCompany·Startup Daily·SmartCompany·Startup Daily·Startup Daily·SmartCompany